Multi-Disciplinary Organization Dedicated to Promoting Advances in
Neuro-Oncology Through Research and Education

Brain Tumor Symposium - Northwestern University


The Brain Tumor Symposium will present the most up-to-date research on brain tumors and the translational application of knowledge to design clinical trials, the most recent clinical trial outcomes data and its interpretation and application to clinical practice, and the innovations in surgical technique and technology. Recently, there have been exciting technical and technological advances in surgical therapy and newly FDA-approved drugs for the treatment of brain tumor patients. This data will be discussed in dedicated lecture formats and reinforced in case-based discussions.

 Target Audience:

Physicians and nursing staff whose practice includes adult brain tumor patients. Relevant specialty groups include neurological surgery, neurology (neuro-oncology), medical oncology, radiation oncology, rehabilitation/psychiatry, radiology.

 Accreditation Statement :

The Northwestern University’s Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement:

The Northwestern University’s Feinberg School of Medicine designates this educational activity for a maximum of 5.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nursing Accreditation Information:

Northwestern Memorial Hospital is an approved provider of continuing nursing education by the Illinois Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This program is approved for 6.0 contact hours.

Conference Objectives:

·  Discuss the current status of brain tumor molecular profiling and its integration to clinical practice.
·  Examine the scientific rationale behind the development of the Velcade trial.
·  Discuss the indications for endoscopoic or endoscope-assisted surgical procedures.
·  Review the results of using 5-ALA for the resection of gliomas.
·  Discuss the current data on stereotactic radiosurgery for gliomas.
·  Review the Stupp protocol – timing and dose of chemotherapy and radiation therapy.
·  Examine the data for Gliadel in gliomas.
·  Interpret new clinical data of antiangiogenesis therapy.
·  Discuss the current FDA-approved indication of bevacizumab.
·  Discuss the radiographic changes that occur after initiating anti-angiogenesis therapy.
·  Evaluate the phenomenon of pseudoprogression.
·  Review the use and role of steroids and antiepileptic agents.
·  Discuss the utility of non-enzyme inducing antiepileptic agents.
·  Examine the appropriate methods of monitoring for systemic adverse events through the use of laboratory tests.
·  Discuss the current developments in novel therapeutic agents.
·  Review the current clinical trial options.



Organizer Megan Mitchell


Fri, Nov. 6, 2009
8:30 a.m. - 4 p.m.
(GMT-0500) US/Central


Prentice Women's Hospital (Northwestern University Campus)
250 E. Superior St.
Chicago, IL